Preclinical Evaluation of Anxiolytic Agents: An Overview
Abstract
Anxiety disorder is a psychological disorder and associated with stress, tension, fear and threat about future. The pathophysiology of anxiety disorder is not fully understood and hence improper diagnosis leads to increase morbidity and mortality rates. The drugs used for the treatment of anxiety having certain limitation in their use because of their side effects such as sedation, drug dependence, habituation, central complexity and drug withdrawal symptoms. Hence the interest in searching alternative remedies for treatment of anxiety is greatly increased. The interest in area of modification of a drug increases so as to reduce side effects of the drug. Another interesting area is the natural source to find out medicinal plant having anxiolytic activity.References
Downloads
Published
2013-10-16
Issue
Section
Articles
License
“I ……………………………………….certify that I have participated sufficiently in the conception and design of this work and the analysis of the data (wherever applicable), as well as the writing of the manuscript, to take public responsibility for it. I believe the manuscript represents valid work. I have reviewed the final version of the manuscript and approve it for publication. Neither has the manuscript nor one with substantially similar content under my authorship been published nor is being considered for publication elsewhere, except as described in an attachment. Furthermore I attest that I shall produce the data upon which the manuscript is based for examination by the editors or their assignees, if requested.â€##SUBMISSION.HOWTOCITE##
Preclinical Evaluation of Anxiolytic Agents: An Overview. (2013). Journal of Pharmaceutical Research and Opinion, 1(1). http://www.innovativejournal.in/index.php/jpro/article/view/513